Terms: = Germ cell tumor AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Treatment
817 results:
1. The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy.
Yadav S; Lawhn-Heath C; Paciorek A; Lindsay S; Mirro R; Bergsland EK; Hope TA
J Nucl Med; 2024 Mar; 65(3):409-415. PubMed ID: 38428966
[TBL] [Abstract] [Full Text] [Related]
2. Guidelines for outpatient administration of naxitamab: Experience from Atrium Health Levine Children's Hospital.
Trovillion EM; Michael M; Jordan CC; Brown L; Phillips K; Oesterheld J; Saulnier-Sholler G
Cancer Med; 2024 Feb; 13(3):e7045. PubMed ID: 38396377
[TBL] [Abstract] [Full Text] [Related]
3. The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy.
Stepanenko AA; Sosnovtseva AO; Valikhov MP; Chernysheva AA; Abramova OV; Naumenko VA; Chekhonin VP
Front Immunol; 2024; 15():1326757. PubMed ID: 38390330
[TBL] [Abstract] [Full Text] [Related]
4. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract] [Full Text] [Related]
5. Liver metastases of neuroendocrine tumors: Conventional transarterial chemoembolization and thermal ablation.
Vogl TJ; Gruber-Rouh T; Naguib NNN; Lingwal N; Bolik P
Rofo; 2024 Apr; 196(4):381-389. PubMed ID: 38109897
[TBL] [Abstract] [Full Text] [Related]
6. The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Kilburn LB; Khuong-Quang DA; Hansford JR; Landi D; van der Lugt J; Leary SES; Driever PH; Bailey S; Perreault S; McCowage G; Waanders AJ; Ziegler DS; Witt O; Baxter PA; Kang HJ; Hassall TE; Han JW; Hargrave D; Franson AT; Yalon Oren M; Toledano H; Larouche V; Kline C; Abdelbaki MS; Jabado N; Gottardo NG; Gerber NU; Whipple NS; Segal D; Chi SN; Oren L; Tan EEK; Mueller S; Cornelio I; McLeod L; Zhao X; Walter A; Da Costa D; Manley P; Blackman SC; Packer RJ; Nysom K
Nat Med; 2024 Jan; 30(1):207-217. PubMed ID: 37978284
[TBL] [Abstract] [Full Text] [Related]
7. NRF1 Alleviated Oxidative Stress of Glioblastoma cells by Regulating nor1.
Wang J; Chen S; Xiang W; Zhu Q; Ren N
Folia Biol (Praha); 2023; 69(1):13-21. PubMed ID: 37962027
[TBL] [Abstract] [Full Text] [Related]
8. Primary brain tumours in adults.
van den Bent MJ; Geurts M; French PJ; Smits M; Capper D; Bromberg JEC; Chang SM
Lancet; 2023 Oct; 402(10412):1564-1579. PubMed ID: 37738997
[TBL] [Abstract] [Full Text] [Related]
9. Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.
Visioli A; Trivieri N; Mencarelli G; Giani F; Copetti M; Palumbo O; Pracella R; Cariglia MG; Barile C; Mischitelli L; Soriano AA; Palumbo P; Legnani F; DiMeco F; Gorgoglione L; Pesole G; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2023 Sep; 42(1):244. PubMed ID: 37735434
[TBL] [Abstract] [Full Text] [Related]
10. Surgical outcome of spinal schwannoma and neurofibroma.
Ferreira Filho AC; Blanco CMB; Trindade JVC; Mattos GB; Joaquim AF
Rev Assoc Med Bras (1992); 2023; 69(9):e20230190. PubMed ID: 37729358
[TBL] [Abstract] [Full Text] [Related]
11. Adamantinomatous craniopharyngioma: evolution in the management.
Massimi L; Palombi D; Musarra A; Bianchi F; Frassanito P; Tamburrini G; Di Rocco C
Childs Nerv Syst; 2023 Oct; 39(10):2613-2632. PubMed ID: 37728836
[TBL] [Abstract] [Full Text] [Related]
12. Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma.
Mangó K; Fekete F; Kiss ÁF; Erdős R; Fekete JT; Bűdi T; Bruckner E; Garami M; Micsik T; Monostory K
Sci Rep; 2023 Jul; 13(1):11770. PubMed ID: 37479763
[TBL] [Abstract] [Full Text] [Related]
13. Gene Expression and Early Radiation Response of Two Distinct Neuroblastoma cell Lines.
Ritner C; Popović J; Abouzeid A; Li Y; Paunesku T; Papineni R; Woloschak G
Oncology; 2023; 101(7):446-456. PubMed ID: 37399803
[TBL] [Abstract] [Full Text] [Related]
14. Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia.
Xue W; Cang W; Zhao J; Feng F; Wan X; Ren T; Qiu L; Yang J; Xiang Y
Int J Gynecol Cancer; 2023 Aug; 33(8):1222-1226. PubMed ID: 37290904
[TBL] [Abstract] [Full Text] [Related]
15. Disease-Modifying Effects of Vincamine Supplementation in
Sanz FJ; Solana-Manrique C; Paricio N
ACS Chem Neurosci; 2023 Jun; 14(12):2294-2301. PubMed ID: 37289979
[TBL] [Abstract] [Full Text] [Related]
16. Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.
Massi D; Szumera-Ciećkiewicz A; Alos L; Simi S; Ugolini F; Palmieri G; Stanganelli I; Cook MG; Mandalà M
Eur J Cancer; 2023 Aug; 189():112921. PubMed ID: 37280145
[TBL] [Abstract] [Full Text] [Related]
17. Midterm outcome after en bloc resection of C2 chordoma with transoral mandibular split and mesh cage reconstruction: a case report.
Korwutthikulrangsri E; Ongard S; Pisutbenya J; Ruangchainikom M; Sutipornpalangkul W
J Med Case Rep; 2023 Jun; 17(1):229. PubMed ID: 37268958
[TBL] [Abstract] [Full Text] [Related]
18. European Neuroendocrine tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.
Sorbye H; Grande E; Pavel M; Tesselaar M; Fazio N; Reed NS; Knigge U; Christ E; Ambrosini V; Couvelard A; Tiensuu Janson E
J Neuroendocrinol; 2023 Mar; 35(3):e13249. PubMed ID: 36924180
[TBL] [Abstract] [Full Text] [Related]
19. Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular germ cell tumors.
Schepisi G; Gianni C; Cursano MC; Gallà V; Menna C; Casadei C; Bleve S; Lolli C; Martinelli G; Rosti G; De Giorgi U
Front Immunol; 2023; 14():1118610. PubMed ID: 36860862
[TBL] [Abstract] [Full Text] [Related]
20. Use of Trametinib in Children and Young Adults With Progressive Low-grade Glioma and Glioneuronal tumors.
Hanzlik E; Archambault B; El-Dairi M; Schroeder K; Patel MP; Lipp ES; Peters KB; Ashley DM; Landi D
J Pediatr Hematol Oncol; 2023 May; 45(4):e464-e470. PubMed ID: 36730221
[TBL] [Abstract] [Full Text] [Related]
[Next]
